Total Payments
$28,578
2024 Payments
$3,425
Companies
40
Transactions
516
Medicare Patients
3,714
Medicare Billing
$810,307
Payment Breakdown by Category
Food & Beverage$28,578 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $28,578 | 516 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| BIOTRONIK INC. | $5,442 | 58 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $5,077 | 52 | $0 (2020) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $3,392 | 38 | $0 (2024) |
| SANOFI-AVENTIS U.S. LLC | $2,886 | 32 | $0 (2024) |
| Mannkind Corporation | $2,572 | 55 | $0 (2024) |
| CeQur Corporation | $1,305 | 2 | $0 (2024) |
| Novo Nordisk Inc | $966.70 | 30 | $0 (2024) |
| Dexcom, Inc. | $604.44 | 18 | $0 (2024) |
| Merck Sharp & Dohme LLC | $553.60 | 25 | $0 (2023) |
| Abbott Laboratories | $494.19 | 16 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $3,425 | 74 | CeQur Corporation ($755.69) |
| 2023 | $2,881 | 76 | CeQur Corporation ($549.14) |
| 2022 | $3,578 | 95 | BIOTRONIK INC. ($580.85) |
| 2021 | $4,564 | 100 | BIOTRONIK INC. ($1,134) |
| 2020 | $1,892 | 37 | AstraZeneca Pharmaceuticals LP ($454.88) |
| 2019 | $3,557 | 36 | AstraZeneca Pharmaceuticals LP ($1,108) |
| 2018 | $4,532 | 48 | AstraZeneca Pharmaceuticals LP ($1,614) |
| 2017 | $4,149 | 50 | AstraZeneca Pharmaceuticals LP ($1,901) |
All Payment Transactions
516 individual payment records from CMS Open Payments — Page 1 of 21
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/17/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $27.46 | General |
| Category: Diabetes Care | ||||||
| 12/13/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $16.74 | General |
| Category: Diabetes | ||||||
| 12/05/2024 | Mannkind Corporation | AFREZZA (Drug) | Food and Beverage | In-kind items and services | $15.46 | General |
| Category: DIABETES MEDICINE | ||||||
| 12/04/2024 | Xeris Pharmaceuticals, Inc. | GVOKE HYPOPEN (Drug) | Food and Beverage | In-kind items and services | $18.64 | General |
| Category: Diabetes | ||||||
| 11/21/2024 | SANOFI-AVENTIS U.S. LLC | TZIELD (Biological) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Endocrine & Metabolic Diseases | ||||||
| 11/17/2024 | Amphastar Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $21.98 | General |
| 11/14/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $16.76 | General |
| Category: Diabetes | ||||||
| 11/07/2024 | Xeris Pharmaceuticals, Inc. | GVOKE HYPOPEN (Drug) | Food and Beverage | In-kind items and services | $23.59 | General |
| Category: Diabetes | ||||||
| 11/04/2024 | Corcept Therapeutics | Korlym (Drug) | Food and Beverage | In-kind items and services | $26.88 | General |
| Category: Endocrinology | ||||||
| 10/29/2024 | Amneal Pharmaceuticals LLC | UNITHROID (Drug) | Food and Beverage | In-kind items and services | $20.56 | General |
| Category: ENDOCRINOLOGY | ||||||
| 10/24/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $19.83 | General |
| Category: Diabetes | ||||||
| 10/16/2024 | Mannkind Corporation | AFREZZA (Drug) | Food and Beverage | In-kind items and services | $157.25 | General |
| Category: DIABETES MEDICINE | ||||||
| 10/08/2024 | Amneal Pharmaceuticals LLC | UNITHROID (Drug) | Food and Beverage | In-kind items and services | $17.55 | General |
| Category: ENDOCRINOLOGY | ||||||
| 10/03/2024 | Mannkind Corporation | AFREZZA (Drug) | Food and Beverage | In-kind items and services | $21.42 | General |
| Category: DIABETES MEDICINE | ||||||
| 10/03/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $15.41 | General |
| Category: Diabetes | ||||||
| 09/25/2024 | BIOTRONIK INC. | Acticor 7 VR-T DX (Device) | Food and Beverage | In-kind items and services | $178.43 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 09/19/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $23.97 | General |
| Category: Cardio-renal | ||||||
| 09/19/2024 | Mannkind Corporation | AFREZZA (Drug) | Food and Beverage | In-kind items and services | $23.23 | General |
| Category: DIABETES MEDICINE | ||||||
| 08/31/2024 | Mannkind Corporation | AFREZZA (Drug) | Food and Beverage | In-kind items and services | $14.84 | General |
| Category: DIABETES MEDICINE | ||||||
| 08/29/2024 | Amneal Pharmaceuticals LLC | UNITHROID (Drug) | Food and Beverage | In-kind items and services | $25.79 | General |
| Category: ENDOCRINOLOGY | ||||||
| 08/28/2024 | BETA BIONICS, INC. | iLet Bionic Pancreas (Device), iLet Bionic Pancreas, iLet Bionic Pancreas | Food and Beverage | In-kind items and services | $23.00 | General |
| Category: Automated insulin delivery system | ||||||
| 08/23/2024 | Esperion Therapeutics, Inc. | NEXLETOL (Drug) | Food and Beverage | In-kind items and services | $17.82 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 08/22/2024 | Xeris Pharmaceuticals, Inc. | GVOKE HYPOPEN (Drug) | Food and Beverage | In-kind items and services | $14.57 | General |
| Category: Diabetes | ||||||
| 08/22/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $13.27 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 08/20/2024 | Amneal Pharmaceuticals LLC | UNITHROID (Drug) | Food and Beverage | In-kind items and services | $19.60 | General |
| Category: ENDOCRINOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 11 | 902 | 2,700 | $350,462 | $218,487 |
| 2022 | 19 | 1,226 | 2,987 | $553,535 | $245,662 |
| 2021 | 17 | 919 | 2,489 | $510,350 | $207,292 |
| 2020 | 14 | 667 | 1,546 | $381,269 | $138,866 |
Total Patients
3,714
Total Services
9,722
Medicare Billing
$810,307
Procedure Codes
61
All Medicare Procedures & Services
61 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 219 | 1,679 | $167,900 | $120,351 | 71.7% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 132 | 155 | $38,850 | $24,181 | 62.2% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 77 | 172 | $25,800 | $18,538 | 71.9% |
| 99497 | Advance care planning, first 30 minutes | Facility | 2023 | 187 | 235 | $35,250 | $15,976 | 45.3% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 102 | 121 | $30,250 | $14,339 | 47.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 58 | 135 | $25,390 | $13,881 | 54.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 38 | 78 | $11,400 | $5,740 | 50.3% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2023 | 16 | 17 | $4,250 | $2,764 | 65.0% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 51 | 86 | $7,227 | $1,049 | 14.5% |
| A9500 | Technetium tc-99m sestamibi, diagnostic, per study dose | Office | 2023 | 11 | 11 | $2,350 | $1,036 | 44.1% |
| 93015 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | Office | 2023 | 11 | 11 | $1,795 | $633.31 | 35.3% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 248 | 1,679 | $219,345 | $111,542 | 50.9% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 182 | 213 | $68,343 | $39,207 | 57.4% |
| 99497 | Advance care planning, first 30 minutes | Facility | 2022 | 225 | 275 | $50,487 | $19,878 | 39.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 80 | 167 | $42,822 | $18,528 | 43.3% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Office | 2022 | 32 | 32 | $62,351 | $14,312 | 23.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 65 | 124 | $22,402 | $9,659 | 43.1% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 68 | 75 | $21,542 | $9,586 | 44.5% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2022 | 33 | 34 | $16,350 | $6,538 | 40.0% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 26 | 44 | $11,290 | $4,218 | 37.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 24 | 24 | $8,849 | $3,112 | 35.2% |
| A9500 | Technetium tc-99m sestamibi, diagnostic, per study dose | Office | 2022 | 32 | 32 | $7,420 | $3,057 | 41.2% |
| 93015 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | Office | 2022 | 33 | 33 | $5,704 | $1,862 | 32.6% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 69 | 130 | $7,296 | $1,597 | 21.9% |
| J2785 | Injection, regadenoson, 0.1 mg | Office | 2022 | 20 | 20 | $3,400 | $953.31 | 28.0% |
About Dr. Jaideep Reddy, M.D
Dr. Jaideep Reddy, M.D is a Cardiovascular Disease healthcare provider based in Richmond Hill, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/03/2006. The National Provider Identifier (NPI) number assigned to this provider is 1841392305.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Jaideep Reddy, M.D has received a total of $28,578 in payments from pharmaceutical and medical device companies, with $3,425 received in 2024. These payments were reported across 516 transactions from 40 companies. The most common payment nature is "Food and Beverage" ($28,578).
As a Medicare-enrolled provider, Reddy has provided services to 3,714 Medicare beneficiaries, totaling 9,722 services with total Medicare billing of $810,307. Data is available for 4 years (2020–2023), covering 61 distinct procedure/service records.
Ad
Practice Information
- Specialty Cardiovascular Disease
- Location Richmond Hill, NY
- Active Since 09/03/2006
- Last Updated 11/10/2023
- Taxonomy Code 207RC0000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1841392305
Products in Payments
- FARXIGA (Drug) $4,713
- JARDIANCE (Drug) $3,218
- AFREZZA (Drug) $2,572
- CeQur Simplicity (Device) $1,305
- SOLIQUA (Drug) $1,046
- Acticor 7 VR-T DX (Device) $898.53
- Ozempic (Drug) $682.87
- TOUJEO (Drug) $653.61
- Dexcom G6 Transmitter (Medical Supply) $559.60
- SOLIQUA 100/33 (Biological) $495.89
- UNITHROID (Drug) $479.35
- Kerendia (Drug) $452.17
- Pogo Automatic Blood Glucose Monitoring System (Device) $405.26
- SOLIQUA 100/33 (Drug) $375.79
- Edora (Device) $355.75
- VERQUVO (Drug) $342.09
- BYDUREON (Drug) $332.73
- Livalo (Drug) $304.71
- CYCLOSET (Drug) $298.90
- INVOKANA (Drug) $295.96
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Cardiovascular Disease Doctors in Richmond Hill
Dr. Aditya Mangla, D.o, D.O
Cardiovascular Disease — Payments: $77,431
Cardiovascular Disease $77,431
Dr. David Schechter, M.d., F.a.c.c., P.c, M.D., F.A.C.C., P.C
Cardiovascular Disease — Payments: $9,569
Cardiovascular Disease $9,569
Vivian Abascal, Md, MD
Cardiovascular Disease — Payments: $9,115
Cardiovascular Disease $9,115
Dr. Arun Mangla, Md, MD
Cardiovascular Disease — Payments: $3,244
Cardiovascular Disease $3,244
Dr. Daniel Deckler, Md, MD
Cardiovascular Disease — Payments: $13.08
Cardiovascular Disease $13.08
Amtul Mansoor, Md, MD
Cardiovascular Disease
Cardiovascular Disease